uridine triphosphate has been researched along with Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, X; Shi, XY; Tian, ML; Wang, CC; Xu, HT; Yuan, HB; Zhu, QF; Zou, Z | 1 |
| Marrelli, SP | 1 |
2 other study(ies) available for uridine triphosphate and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Uridine 5'-triphosphate (UTP) protects against cerebral ischemia reperfusion injury in rats.
Topics: Animals; Brain; Cell Death; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Magnetic Resonance Imaging; Male; Microscopy, Electron; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Severity of Illness Index; Tetrazolium Salts; Uridine Triphosphate; Water | 2009 |
Altered endothelial Ca2+ regulation after ischemia/reperfusion produces potentiated endothelium-derived hyperpolarizing factor-mediated dilations.
Topics: Adenosine Triphosphate; Animals; Biological Factors; Brain Ischemia; Calcium; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Fluorescent Dyes; In Vitro Techniques; Infarction, Middle Cerebral Artery; Ionophores; Male; Middle Cerebral Artery; Rats; Rats, Long-Evans; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y2; Reperfusion; Thionucleotides; Uridine Triphosphate; Vascular Patency; Vasodilation | 2002 |